Feb 03, 2014 8:35 am EST Heat Biologics, Inc. Announces Formation of Clinical Advisory Board With Preeminent Immunotherapy and Oncology Experts
Jan 17, 2014 8:05 am EST Heat Biologics, Inc. to Present at "TEN"; Noble Financial Capital Markets' Tenth Annual Equity Conference on Tuesday, January 21, 2014
Dec 30, 2013 1:15 pm EST Heat Biologics Announces Its Phase 1/2 Study of HS-410 in Bladder Cancer Is Open for Enrollment
Dec 17, 2013 8:00 am EST Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development
Dec 02, 2013 8:05 am EST Heat Biologics, Inc. to Present at 25th Annual Piper Jaffray Healthcare Conference
Nov 25, 2013 8:30 am EST Heat Biologics Successfully Completes Manufacturing of HS-410 to Start Phase 1/2 Bladder Cancer Trial
Nov 14, 2013 9:20 am EST Heat Biologics, Inc. Reports Third Quarter 2013 Financial Results and Provides Clinical Programs Review